损伤一号方联合双氯芬酸钠缓释片治疗急性软组织损伤临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R274.3

基金项目:


Clinical Study on Injury No.1 Prescription Combined with Diclofenac Sodium Sustained-Release Tablets for Acute Soft Tissue Injury
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察损伤一号方联合双氯芬酸钠缓释片治疗急性软组织损伤的临床疗效。方法:选取 100 例急性软组织损伤患者以随机数字表法分为观察组与对照组各50 例。2 组均给予双氯芬酸钠缓释片治疗, 观察组在对照组基础上联合中药损伤一号方治疗,治疗2 周。比较2 组临床疗效,比较2 组治疗前后中医证候 评分、血液流变学指标及血清炎症因子水平。结果:观察组总有效率96.00%,高于对照组84.00% (P< 0.05)。治疗后,2 组疼痛、肿胀、肢体活动受限、瘀斑、失眠、口干、便秘等中医证候评分均降低(P< 0.05),且观察组低于对照组(P<0.05)。治疗后,2 组血浆黏度、全血黏度低切、全血黏度高切及纤维蛋白原 水平均降低(P<0.05),且观察组低于对照组(P<0.05)。治疗后,2 组血清白细胞介素-1β(IL-1β)、白细 胞介素-6(IL-6) 及肿瘤坏死因子-α(TNF-α) 水平均降低(P<0.05),且观察组低于对照组(P<0.05)。结 论:针对急性软组织损伤患者给予损伤一号方联合双氯芬酸钠缓释片治疗疗效显著,可有效缓解患者临床症 状,改善血液流变学指标,减轻机体炎症反应。

    Abstract:

    Abstract:Objective:To observe the clinical effect of the therapy of Injury No.1 Prescription combined with Diclofenac Sodium Sustained- Release Tablets on acute soft tissue injury. Methods : A total of 100 patients with acute soft tissue injury were randomly divided into the observation group and the control group according to the random number table method,with 50 cases in each group. The two groups were treated with Diclofenac Sodium Sustained- Release Tablets, and the observation group was additionally treated with Chinese medicine Injury No.1 Prescription based on the treatment of the control group. Both groups were treated for 2 weeks. The clinical effects were compared between the two groups, and the traditional Chinese medicine (TCM) syndrome scores, hemorheology indexes and serum inflammatory factors were compared in the two groups before and after treatment. Results:The total effective rate was 96.00% in the observation group, higher than that of 84.00% in the control group (P<0.05). After treatment, the TCM syndrome scores such as pain, swelling, limited limb movement, ecchymosis, insomnia, dry mouth and constipation were all decreased in the two groups (P<0.05), and the above scores in the observation group were lower than those in the control group (P<0.05). After treatment, plasma viscosity,low-shear whole blood viscosity,high-shear whole blood viscosity and fibrinogen in the two groups were decreased on average (P<0.05),and the above indexes in the observation group were lower than those in the control group (P<0.05). After treatment,serum levels of interleukin- 1β (IL- 1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in the two groups were decreased (P<0.05),and the above levels in the observation group were lower than those in the control group (P<0.05). Conclusion: The therapy of Injury No.1 Prescription combined with Diclofenac Sodium Sustained-Release Tablets has a significant therapeutic effect on patients with acute soft tissue injury,which can effectively relieve clinical symptoms,improve hemorheology indexes and reduce inflammation.

    参考文献
    相似文献
    引证文献
引用本文

刘永泉.损伤一号方联合双氯芬酸钠缓释片治疗急性软组织损伤临床研究[J].新中医,2024,56(5):108-112

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-03-14
  • 出版日期:
文章二维码